Detalhe da pesquisa
1.
Small molecules inhibitors of the heterogeneous ribonuclear protein A18 (hnRNP A18): a regulator of protein translation and an immune checkpoint.
Nucleic Acids Res
; 49(3): 1235-1246, 2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398344
2.
Transducin ß-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.
Haematologica
; 106(11): 2927-2939, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054136
3.
WNT Signaling as a Therapeutic Target for Glioblastoma.
Int J Mol Sci
; 22(16)2021 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445128
4.
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer.
Br J Cancer
; 123(6): 1024-1032, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581342
5.
Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Mol Carcinog
; 58(10): 1770-1782, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31219654
6.
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.
J Transl Med
; 15(1): 210, 2017 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29047383
7.
Increased interaction between connexin43 and microtubules is critical for glioblastoma stem-like cell maintenance and tumorigenicity.
bioRxiv
; 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328202
8.
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer.
bioRxiv
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328254
9.
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
Mol Cancer Res
; 21(1): 3-13, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149636
10.
Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE.
Eur J Med Chem
; 227: 113926, 2022 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735919
11.
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Sci Transl Med
; 14(635): eabb7695, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263148
12.
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells.
J Med Chem
; 64(14): 9916-9925, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210138
13.
Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells.
Clin Transl Med
; 11(12): e625, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919342
14.
The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer.
Cancer Res
; 81(8): 2044-2055, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33574092
15.
Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic ß-Catenin.
Cancer Prev Res (Phila)
; 14(11): 995-1008, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584001
16.
Kinetic behaviour of WT 1's zinc finger domain in binding to the alpha-actinin-1 mRNA.
Arch Biochem Biophys
; 497(1-2): 21-7, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20193655
17.
Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in colon carcinoma cells.
Cell Cycle
; 19(13): 1590-1601, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32423265
18.
Cellular thermal shift analysis for interrogation of CRISPR-assisted proteomic changes.
Biotechniques
; 68(4): 180-184, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040335
19.
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis.
Oncotarget
; 11(43): 3863-3885, 2020 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196708
20.
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders.
J Med Chem
; 63(6): 2854-2876, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096640